CARA — Cara Therapeutics Cashflow Statement
0.000.00%
Last trade - 00:00
- $18.84m
- -$50.94m
- $20.97m
- 26
- 56
- 18
- 25
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -106 | 8.41 | -88.4 | -85.5 | -119 |
Depreciation | |||||
Non-Cash Items | -3.96 | -6.74 | 22.8 | 19.4 | 16.8 |
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | 0.909 | -7.37 | 5.26 | -12.9 | 9.36 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Prepaid Expenses | |||||
Change in Accrued Expenses | |||||
Change in Payable / Accrued Expenses | |||||
Net Change in Other Assets & Liabilities | |||||
Cash from Operating Activities | -109 | -5.49 | -60.1 | -78.7 | -92.1 |
Capital Expenditures | -0.018 | -0.349 | -0.039 | -0.043 | -2.38 |
Purchase of Fixed Assets | |||||
Other Investing Cash Flow Items | -30.5 | -19.9 | -4.71 | 129 | 45.8 |
Sale of Fixed Assets | |||||
Sale/Maturity of Investment | |||||
Purchase of Investments | |||||
Cash from Investing Activities | -30.5 | -20.3 | -4.75 | 129 | 43.5 |
Financing Cash Flow Items | — | — | — | — | 36.5 |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Cash from Financing Activities | 143 | 39.1 | 46.6 | 0.311 | 38.2 |
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 2.86 | 13.4 | -18.2 | 50.3 | -10.5 |